Correlation Between Cabio Biotech and Kuang Chi

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cabio Biotech and Kuang Chi at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cabio Biotech and Kuang Chi into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cabio Biotech Wuhan and Kuang Chi Technologies, you can compare the effects of market volatilities on Cabio Biotech and Kuang Chi and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cabio Biotech with a short position of Kuang Chi. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cabio Biotech and Kuang Chi.

Diversification Opportunities for Cabio Biotech and Kuang Chi

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cabio and Kuang is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Cabio Biotech Wuhan and Kuang Chi Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kuang Chi Technologies and Cabio Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cabio Biotech Wuhan are associated (or correlated) with Kuang Chi. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kuang Chi Technologies has no effect on the direction of Cabio Biotech i.e., Cabio Biotech and Kuang Chi go up and down completely randomly.

Pair Corralation between Cabio Biotech and Kuang Chi

Assuming the 90 days trading horizon Cabio Biotech Wuhan is expected to under-perform the Kuang Chi. In addition to that, Cabio Biotech is 1.09 times more volatile than Kuang Chi Technologies. It trades about -0.03 of its total potential returns per unit of risk. Kuang Chi Technologies is currently generating about 0.07 per unit of volatility. If you would invest  1,811  in Kuang Chi Technologies on October 16, 2024 and sell it today you would earn a total of  2,234  from holding Kuang Chi Technologies or generate 123.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cabio Biotech Wuhan  vs.  Kuang Chi Technologies

 Performance 
       Timeline  
Cabio Biotech Wuhan 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cabio Biotech Wuhan are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Cabio Biotech may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Kuang Chi Technologies 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Kuang Chi Technologies are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Kuang Chi sustained solid returns over the last few months and may actually be approaching a breakup point.

Cabio Biotech and Kuang Chi Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cabio Biotech and Kuang Chi

The main advantage of trading using opposite Cabio Biotech and Kuang Chi positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cabio Biotech position performs unexpectedly, Kuang Chi can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kuang Chi will offset losses from the drop in Kuang Chi's long position.
The idea behind Cabio Biotech Wuhan and Kuang Chi Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Content Syndication
Quickly integrate customizable finance content to your own investment portal
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity